We narrowed to 430 results for: lenticrispr v2

#104993

This 3rd generation lentiviral plasmid expresses a S. pyogenes CRISPR chimeric RNA element with customizable sgRNA from a U6 promoter and blasticidin S resistance from an EF-1a promoter.

Brett Stringer

Stringer et al Sci Rep. 2019 Mar 20;9(1):4902. doi: 10.

Aug. 10, 2018

Academic Institutions and Nonprofits only

#104991

This 3rd generation lentiviral plasmid expresses a S. pyogenes CRISPR chimeric RNA element with customizable sgRNA from a U6 promoter and hygromycin resistance from an EF-1a promoter.

Brett Stringer

Stringer et al Sci Rep. 2019 Mar 20;9(1):4902. doi: 10.

Aug. 10, 2018

Academic Institutions and Nonprofits only

#114199

Lentivirus compatible SpCas9/dCas9 sgRNA scaffold driven by the U6 promoter and mCherry driven by the EF1a promoter

Jeremy Day

Savell et al eNeuro. 2019 Mar 7;6(1). pii: eN-MNT-049

Sept. 7, 2018

Academic Institutions and Nonprofits only

#104990

This 3rd generation lentiviral plasmid expresses a S. pyogenes CRISPR chimeric RNA element with customizable sgRNA from a U6 promoter and puromycin resistance from an EF-1a promoter.

Brett Stringer

Stringer et al Sci Rep. 2019 Mar 20;9(1):4902. doi: 10.

Aug. 10, 2018

Academic Institutions and Nonprofits only

#104995

This lentiviral construct delivers hSpCas9 and hygromycin resistance.

Brett Stringer

Stringer et al Sci Rep. 2019 Mar 20;9(1):4902. doi: 10.

Aug. 10, 2018

Academic Institutions and Nonprofits only

#104992

This 3rd generation lentiviral plasmid expresses a S. pyogenes CRISPR chimeric RNA element with customizable sgRNA from a U6 promoter and G418 (neomycin) resistance from an EF-1a promoter.

Brett Stringer

Stringer et al Sci Rep. 2019 Mar 20;9(1):4902. doi: 10.

Aug. 10, 2018

Academic Institutions and Nonprofits only

#90085

This plasmid contains destabilized Cas9 and has Venus after P2A sequence. This vector also contains filler sequence which required to be removed for cloning of desired sgRNA

Raffaella Sordella

Senturk et al Nat Commun. 2017 Feb 22;8:14370. doi: 10

July 21, 2017

Academic Institutions and Nonprofits only

#104996

This lentiviral construct delivers hSpCas9 and G418 resistance.

Brett Stringer

Stringer et al Sci Rep. 2019 Mar 20;9(1):4902. doi: 10.

Aug. 10, 2018

Academic Institutions and Nonprofits only

#82415

Lentiviral vector expressing Cre recombinase alongside Cas9 and an sgRNA cloning site

David Feldser

Walter et al Cancer Res. 2017 Feb 15. pii: canres.215

Sept. 9, 2016

Academic Institutions and Nonprofits only

#114195

Lentivirus compatible dCas9-VPR construct driven by the EF1a promoter

Jeremy Day

Savell et al eNeuro. 2019 Mar 7;6(1). pii: eN-MNT-049

Sept. 7, 2018

Academic Institutions and Nonprofits only